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NASA, Lawrence Livermore National Laboratory (LLNL) and 
the Department of Defense (DoD) share a common interest in 
compact medical diagnostic technologies—also known as 
“point of care testing” (POCT) technologies. For NASA, the 
need is to take care of astronauts on deep space missions.  For 
LLNL, the focus is on technologies needed to support 
homeland security applications.  For DoD, the need is to 
support warfighters in military theaters of operation, 
especially for prolonged field care and en route care.
A recently patented technology, “Portable Medical Diagnosis 
Instrument” (U.S. Patent 9824870), co-invented by NASA and 
LLNL, is being developed further in a partnership between 
NASA, LLNL and Travis Air Force Base, with a focus on military 
applications. This instrument, the NASA-LLNL Medical 
Tricorder, can be used for a wide range of clinical samples 
including breath, saliva and blood.  One component of the 
Tricorder is the NASA E-Nose, a carbon nanotube-based 
chemical sensor, integrated into a hand-held smart phone, that 
can detect and measure “breath biomarkers” in the gas phase 
of exhaled breath.  The response of the NASA E-Nose is rapid, 
which makes it possible to detect various gas-phase 
substances in real time. The NASA E-Nose, with modification, 
can also be used for breath condensate analysis. 
Another component of the Tricorder is a miniaturized 
microfluidic analyzer, under development by LLNL, that does 
not require any pumps. The microfluidic analyzer can detect 
and measure biomarkers in liquid samples, such as blood, 
saliva and breath condensate.  This microfluidic system 
requires small quantities of liquid sample and can perform 
analysis very rapidly (seconds to minutes), which makes it 
possible to detect relevant biomarkers in near real time in the 
field.
The Clinical Investigation Facility (CIF) at Travis Air Force Base 
is currently conducting research with the goal to develop 
improved field-able technologies and procedures for the 
emergency response to life threatening injuries soldiers may 
receive in theater. This work includes experimental large 
animal systems and comprehensive collection of clinical 
specimens and physiological data.  NASA and LLNL are 
partnering with Travis to test and further develop the Tricorder
technology for high priority military applications, initially 
focused on lung injury models and traumatic brain injury.
ABSTRACT INTRODUCTION
Point of care (POC) diagnostic 
technology has the potential to 
provide critical information needed 
to improve in theater medical care, 
especially care that extends beyond 
the “Golden Hour” (prolonged field 
care and en route care).  Although 
no POC technology can fully replace 
the capabilities of a fully equipped 
clinical laboratory, measurement of 
key biomarkers can be extremely 
helpful, especially those that reveal 
damage to specific organ systems, 
for both trauma patients and non-
trauma patients.
While POC technology based on 
single, component technologies is 
the norm, we present here a novel 
technology that combines two
component technologies—a breath 
analysis technology and a 
microfluidic system.  This strategy 
results in an instrument with far 
more diagnostic capability than 
would be possible with just a single 
component technology, including 
the ability to analyze both 
minimally invasive specimens 
(blood) and non-invasive specimens 
(breath and saliva).
TECHNOLOGY DESCRIPTION DISCUSSION
• Compact size, low mass and ruggedness define the 
chief characteristics needed for Point of Care 
(POC) diagnostic instruments needed by NASA, 
Homeland Security and Military Medicine.
• The NASA-LLNL Medical Tricorder is capable of 
measuring broad classes of biomarkers: blood cells 
(complete blood count, white cell differential), 
breath volatiles, and a wide spectrum of peptides 
and proteins from blood, breath and saliva.
• Current projects just getting underway include 
biomarker analysis in disease models for acute 
respiratory distress syndrome (ARDS), pulmonary 
contusion (blast injury) and sepsis in experimental 
pigs at the CIF at Travis Air Force Base.
• Other disease models of interest include models 
of traumatic brain injury (TBI), acute renal damage 
and other forms of battlefield-related disease, as 
well as tropical diseases and other infections.
SUMMARY
• The NASA LLNL Medical Tricorder combines two 
proven technologies—NASA E-Nose for breath 
analysis and a LLNL-developed microfluidic 
system—for comprehensive analysis of 
biomarkers to support far forward military 
medical needs.
CONTACT
• The NASA-LLNL Medical Tricorder is a strategic combination of two 
proven technologies—a LLNL-developed microfluidic system (left) 
and a breath analysis system (NASA E-Nose) shown on the right.
• Each component has been under development for 10+ years.
The Microfluidic System 
makes measurements on 50-
100 µl blood samples, or 
comparable volumes of saliva, 
and is capable of enumerating 
blood cells and performing a 
white cell differential, or 
measuring peptides/proteins 
in the sample.  Hydrophobic 
valves control fluid movement 
driven by centrifugal force.
NASA-LLNL Medical “Tricorder”
The NASA E-Nose breath 
analysis system uses carbon 
nanotube sensor elements on 
a silicon chip to detect a 
variety of volatile compounds.  
The multiplexed system uses 
machine learning algorithms 
to interpret the differential 
response of the sensor 
elements to analyze exhaled 
breath specimens for specific 
biomarkers.  
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